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Pntravascular Ultrasound-Guided
reatment for Angiographically
ndeterminate Left Main Coronary Artery Disease
Long-Term Follow-Up Study
mir-Ali Fassa, MD, Kenji Wagatsuma, MD, Stuart T. Higano, MD, Verghese Mathew, MD,
regory W. Barsness, MD, Ryan J. Lennon, MS, David R. Holmes, JR, MD, Amir Lerman, MD
ochester, Minnesota
OBJECTIVES The purpose of this study was to evaluate the efficacy of an intravascular ultrasound
(IVUS)-guided strategy for patients with angiographically indeterminate left main coronary
artery (LMCA) disease.
BACKGROUND The assessment of LMCA lesions using coronary angiography is often challenging; IVUS
provides useful information for assessment of coronary disease.
METHODS Intravascular ultrasound was performed on 121 patients with angiographically normal
LMCAs to determine the lower range of normal minimum lumen area (MLA), defined as the
mean  2 SD. We conducted IVUS studies on 214 patients with angiographically
indeterminate LMCA lesions, and deferral of revascularization was recommended when the
MLA was larger than this predetermined value.
RESULTS The lower range of normal LMCAMLA was 7.5 mm2. Of the patients with angiographically
indeterminate LMCAs, 83 (38.8%) had anMLA7.5 mm2, and 131 (61.2%) anMLA7.5
mm2. Left main coronary artery revascularization was performed in 85.5% (71 of 83) of
patients with an MLA 7.5 mm2 and deferred in 86.9% (114 of 131) of patients with an
MLA 7.5 mm2. Long-term follow-up (mean 3.3  2.0 years) showed no significant
difference in major adverse cardiac events (target vessel revascularization, acute myocardial
infarction, and death) between patients with an MLA 7.5 mm2 who underwent revascu-
larization and those with an MLA7.5 mm2 deferred for revascularization (p 0.28). Based
on outcome, the best cut-off MLA by receiver operating characteristic was 9.6 mm2.
Multivariate predictors of cardiac events were age, smoking, and number of non-LMCA
vessels diseased.
CONCLUSIONS Intravascular ultrasound is an accurate method to assess angiographically indeterminate
lesions of the LMCA. Furthermore, deferring revascularization for patients with a minimum
lumen area 7.5 mm2 appears to be safe. (J Am Coll Cardiol 2005;45:204–11) © 2005 by
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.09.066the American College of Cardiology Foundation
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ceft main coronary artery (LMCA) disease is associated
ith a poor prognosis when treated medically, and its
resence is an indication for coronary artery bypass surgery
CABG), which significantly improves long-term outcome
1–3). Although angiography is considered as the gold
tandard for coronary artery disease assessment, this tech-
ique may present limitations in accurately determining the
ignificance of LMCA lesions (4–8).
Intravascular ultrasound (IVUS) is an accurate method to
etermine vessel dimensions and wall characteristics, and is
ore sensitive than angiography in detecting early athero-
clerosis (9–12). Observations at our institution and others
ave shown that IVUS may be helpful in assessment and
reatment guidance for angiographically indeterminate
MCA disease (13–19).
From the Center of Coronary Physiology and Imaging, Cardiac Catheterization
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ational Institutes of Health (R01 HL63911, R01 HL69840) and the Miami Heart
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cholarship at the Mayo Foundation.c
Manuscript received May 27, 2004; revised manuscript received September 24,
004, accepted September 28, 2004.The purpose of this study is to evaluate the safety and
fficacy of an IVUS-guided strategy for angiographically
ndeterminate LMCA disease, by defining a lower range of
ormal minimum lumen area (MLA), and deferring revas-
ularization for patients who have an MLA larger than this
alue.
ETHODS
atient population. The following study protocol was
pproved by the Mayo Clinic Institutional Review Board.
ll patients included were seen from November 1994 to
eptember 2002. A total of 121 patients who were found to
ave a normal or minimally diseased LMCA on angiogra-
hy underwent IVUS examinations. The lower range of the
ormal MLA was defined as the mean MLA  2 SDs.
ased on this criterion, a recommendation was imple-
ented that all patients with an angiographically indeter-
inate LMCA should undergo IVUS, and that revascular-
zation be performed when the MLA was smaller than the
redefined lower range of normal; IVUS studies were
arried out at the discretion of the treating physician. All
ases in which IVUS had been performed in order to clarify
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January 18, 2005:204–11 Intravascular Ultrasound and Left Main Diseasembiguous angiographic findings, and help determine acute
herapy, were included. During the study period, 231
atients underwent an IVUS study for angiographically
ndeterminate lesions of the LMCA. Seventeen patients
ith the following criteria were excluded from the study: 1)
esearch consent denied by the patient (one patient); 2)
uantitative assessments of IVUS findings was difficult due
o severe calcification or obscure IVUS imagery (two pa-
ients); 3) the IVUS catheter could not be maintained
oaxial to the LMCA during pull-back (three patients); 4)
tent had been previously placed in the LMCA (four
atients); 5) proven spasm of the LMCA (four patients);
nd 6) LMCA revascularization therapy was unclear or
nknown (three patients). Therefore, 214 patients were
ncluded in the present study.
The treatment strategy selection was left to the discretion
f the treating physician and was generally based on the
atients underlying clinical state, in light of the previous
ecommendation of performing revascularization when
LA was found to be smaller than the preestablished lower
ange of normal value.
linical demographics. Hospital records of all the patients
ith angiographically indeterminate LMCA were reviewed
o obtain information on clinical demographics and medical
istory. Follow-up information was obtained through re-
iew of hospital charts, written questionnaires, telephone
nterviews, and the interventional database of the Mayo
linic. Patients were considered to have follow-up only if
nformation was available more than one year after the date
f angiography, unless an adverse event had occurred during
hat period. Major adverse cardiac events (MACE) included
arget vessel revascularization (defined as a percutaneous
oronary intervention [PCI] of the LMCA or CABG to the
eft coronary system due to progression of the LMCA
isease), myocardial infarction (according to the definition
tated by the European Society of Cardiology/American
ollege of Cardiology consensus document [20]), and
ll-cause mortality.
rocedure. Coronary angiography was performed via the
emoral artery approach, with insertion of a 6 to 8F sheath
ollowed by an angiography catheter or guiding catheter of
he same size. Patients received 2,500 U of intravenous
Abbreviations and Acronyms
CABG  coronary artery bypass graft
CSA  cross-sectional area
EEM  external elastic membrane
IVUS  intravascular ultrasound
LMCA  left main coronary artery
MACE  major adverse cardiac events
MLA  minimum lumen area
MLD  minimum lumen diameter
PCI  percutaneous coronary intervention
PM  plaque plus mediaeparin before the angiography procedure. An additional f,000 to 5,000 U of heparin, as well as 0.4 mg of sublingual
itroglycerin were administered before the IVUS examina-
ion. Angiographic assessments of the LMCA were made
rom a minimum of two angles. Two experienced angiog-
aphers reviewed the angiogram, and IVUS examinations
ere conducted to determine the most appropriate therapy.
VUS examination. The IVUS imaging protocol was per-
ormed according to methods as described previously (21,22).
fter angiography, a 0.014-inch guidewire was passed through
6-F to 8-F guiding catheter from the left main to the left
nterior descending or circumflex artery. Intracoronary nitro-
lycerin 200 g was administered to avoid coronary spasm.
he IVUS transducer was inserted up to a point beyond the
ifurcation from the left main to the left anterior descending or
ircumflex artery. Using manual pullback or a motorized
ullback system, images were recorded on a VCR tape. Studies
ere performed using one of three commercially available
ystems. We used a 30-MHz, 3.5-F mechanical scanning
VUS catheter (Cardiovascular Imaging Systems Inc., Boston
cientific, Boston, Massachusetts, and Hewlett-Packard,
ndover, Massachusetts), a 2.9-F or 3.2-F mechanical scan-
ing IVUS catheter (Cardiovascular Imaging Systems Inc.,
oston Scientific Corporation, Boston, Massachusetts), and a
.5-F electronic scanning IVUS (Volcano, Endosonics,
ancho Cordova, California). The Volcano/Endosonics IVUS
bservations were recorded on a CD in addition to a VCR
ape.
uantitative coronary angiography analysis. Quantita-
ive coronary angiography was performed off-line by an
nvestigator unaware of the IVUS findings, using computer-
ssisted edge-detection methods (QCA-CMS version 5.0,
EDIS, Leiden, the Netherlands). The contrast-filled
atheter was used for calibration. Minimal lumen diameter
MLD), reference diameter, and lesion length were mea-
ured in diastolic frames obtained by angiography before
VUS procedures. Percent diameter stenosis was calculated.
he lesion segment was defined as the portion of the vessel
here the lesion was located (ostial, middle of distal).
VUS analysis. Intravascular ultrasound analysis was per-
igure 1. Distribution of 121 patients with an angiographically normal or
inimally diseased left main coronary artery, according to minimum lumen
rtery (MLA).   mean;   standard deviation.ormed according to the methods described in the consensus
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Intravascular Ultrasound and Left Main Disease January 18, 2005:204–11ocument on IVUS studies by the American College of
ardiology (23). The quantitative and qualitative analyses
ere conducted off-line by an investigator unaware of the
linical characteristics or the treatment of the patient, using
he recorded VCR tapes and CD. Hewlett-Packard Sonos
ntravascular, Volcano/Endosonics In-Vision, and CVIS
learView, Boston Scientific, were used for analysis of
VUS observations. Standard calibration markers directly
rom the ultrasound images were used for calibration of
bsolute measurements. Based on images depicted during
ullback of the transducer that had been inserted beyond the
MCA bifurcation into the left anterior descending or
ircumflex artery, the lesion was defined as the image slice
ith the smallest lumen cross-sectional area (CSA).
Quantitative assessment measured the following param-
ters through computer planimetry at the lesion site. Min-
mal lumen area: obtained by tracing the intimal leading
dge. External elastic membrane (EEM) CSA: obtained by
racing the EEM CSA at the lesion site. Plaque plus media
PM) CSA: the difference between EEM CSA and
LA. Minimum lumen diameter: the shortest diameter
hrough the center point of the lumen. Maximum lumen
iameter: the longest diameter through the center point of
he lumen. In addition, plaque burden was calculated as the
atio of PM CSA to EEM CSA (plaque burden [%] 
M CSA  100/EEM CSA).
Qualitative assessments classified plaque properties into
he following four classes. Soft: plaque has less echogenicity
han the adventitia. Calcified: plaque has higher echogenic-
ty than the adventitia accompanied by acoustic shadowing.
ibrous: plaque has echogenicity that falls between that of
alcified and soft plaque. Mixed: plaque composed of two or
ore of the above properties (soft, calcified, fibrous). Cal-
ium score was studied to determine severity of calcification.
ross-sections to be assessed for calcium score were divided
nto quadrants, and classified into five stages according to
alcium occupied area (0 to 4, 0  no calcium, 4  calcium
n all four quadrants).
tatistical analysis. Continuous variables are presented as
ean  SD. Discrete variables are presented as absolute
umbers (percentages). Group differences were compared
ith the unpaired two-sample t test, the one-way analysis of
ariance, Pearson’s chi-square test, or the log-rank test, as
Table 1. Revascularization Therapy of LMCA
MLA <7.5 mm
A
(Revascularization)
n 71 (85.5)
CABG 69 (97.2)
PCI of LMCA 2 (2.8)
Medical therapy only —
PCI of non-LMCA vessels 2 (2.8)
CABG  coronary artery bypass surgery; LMCA  left
percutaneous coronary intervention.ppropriate; MACE curves were constructed according to paplan and Meier (24). All tests were two-tailed at the 0.05
ignificance level. The receiver operating characteristic
ethod according to Contal and O’Quigley (25) was used
o determine the best cut-off point for MLA based on the
utcome. Logistic regression analysis was used to identify
he independent predictors of MACE. Univariate predic-
ors of MACE with a p value 0.05 were entered into the
ultivariate model.
ESULTS
ormal LMCA group. The mean MLA of the 121
atients with an angiographically normal or minimally
iseased LMCA (control group) was 16.25  4.30 mm2
Fig. 1). The lower range of normal value, calculated as the
ean MLA  2 SDs, was 7.65 mm2. Therefore, we used
he near equal value of 7.5 mm2 to establish the threshold
LA for performing revascularization in the patients with
ngiographically indeterminate LMCA disease.
reatment strategy. Among the 214 patients who under-
ent IVUS for angiographically indeterminate LMCA
isease, 83 (38.8%) had an MLA 7.5 mm2 and 131
61.2%) had an MLA 7.5 mm2 (Table 1). The majority
85.5%) of the patients with an MLA7.5 mm2 underwent
evascularization of the LMCA (group A); most (97.2%)
nderwent CABG, and two patients (2.8%) had a stent
mplanted in a protected LMCA (the same two patients
lso underwent PCI of another vessel). There were 12
atients (14.5%) with an MLA7.5 mm2 who were treated
onservatively (group B). The main reasons for deferring
evascularization in these patients were normal fractional
ow reserve of the LMCA (25.0%), patient’s refusal of
ABG (16.7%), advanced age or comorbidities (16.7%),
rior CABG (16.7%), and surgeon’s opinion (8.3%).
mong the patients with an MLA 7.5 mm2, a large
roportion (87.0%) was deferred for revascularization
group D), while the remainder (13.0%) underwent CABG
group C). The main reasons for the latter to undergo
evascularization despite an LMCA lesion considered non-
ignificant by IVUS were three-vessel disease (35.3%), left
nterior descending disease nonamenable to PCI (35.3%),
nd CABG to the left coronary system during a valve
peration for a non-LMCA lesion (6.9%). The CABG
 83) MLA >7.5 mm2 (n  131)
B
(Deferral)
C
(Revascularization)
D
(Deferral)
12 (14.5) 17 (13.0) 114 (87.0)
— 17 (100) —
— 0 —
9 (75.0) — 79 (69.3)
3 (25.0) 0 35 (30.7)
coronary artery; MLA  minimum lumen area; PCI 2 (nrocedures were performed within a few days from angio-
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o patient underwent PCI of an unprotected LMCA.
aseline characteristics. The rate of hyperlipidemia and
amily history of coronary artery disease differed signifi-
antly among the groups, and was highest in group C
Table 2). “Other” indications for angiography, which
ncluded mainly atypical or noncardiac chest pain and
hortness of breath, were more often encountered in
atients who were deferred for revascularization (groups
and D). There were no other significant differences in
aseline characteristics.
ngiography characteristics. There was a significant trend
oward a higher number of non-LMCA vessels diseased
mong the patients who underwent revascularization
groups A and C) (Table 3). Minimum lumen diameter and
he reference diameter were significantly lower in the
Table 2. Baseline Characteristics
MLA <7.5 m
A
(Revascularization
n 71 (85.5)
Age (yrs) 65.1 10.5
Male gender 48 (67.6)
Hypertension 43 (60.6)
Diabetes 10 (14.1)
Hyperlipidemia 43 (60.6)
Smoking* 14 (19.7)
Family history† 42 (59.2)
Prior PCI 17 (23.9)
Prior CABG 5 (7.0)
Body mass index (kg/m2) 28.6  4.9
Body surface area (m2) 1.96  0.23
Ejection fraction (%)‡ 54.7 13.5
Indication for angiography
Angina pectoris 29 (40.9)
Unstable angina 11 (15.5)
Acute myocardial infarction 7 (9.9)
Silent ischemia 5 (7.0)
Other 19 (26.8)
*Active smoking at time of or up to one year before angiogr
patients; §p  0.05 across groups A, B, C, D.
Abbreviations as in Table 1.
Table 3. Angiographic Characteristics
MLA <7.5 mm2
A
(Revascularization)
n 71
Vessels diseased* 2.0 1.0
LMCA lesion location
Ostium 35 (49.3)
Middle 14 (19.7)
Distal 22 (31.0)
MLD (mm) 2.3  0.5
Reference diameter (mm) 3.6 0.7
Diameter stenosis (%) 35.0  10.7
Lesion length (mm) 4.1  2.2*Number of vessels diseased excluding the LMCA; †p  0.05 acro
MLD  minimum lumen diameter; other abbreviations as in Tatients who had an MLA 7.5 mm2, in contrast with the
ack of difference in the degree of stenosis and lesion length
etween the four groups. There were no significant differ-
nces in the location of the LMCA lesion.
VUS characteristics. Patients in groups A and B had a
ignificantly smaller EEM CSA, MLD, and maximum
umen diameter, as well as a higher plaque burden and
alcium score than in groups C and D (Table 4). Further-
ore, patients in the control group did have a limited
egree of atherosclerosis. Additionally, during IVUS exam-
nation, two patients (0.9%) experienced transient chest pain
ith ST-segment change, which rapidly resolved after
iscontinuation of the examination; there was no associated
yocardial injury.
ong-term outcome. Overall follow-up was obtained for
85 (86.4%) patients, for a mean period of 3.5  2.1 years
 83) MLA >7.5 mm2 (n  131)
B
(Deferral)
C
(Revascularization)
D
(Deferral)
12 (14.5) 17 (12.9) 114 (87.0)
65.3  8.9 62.4  7.6 64.5  10.9
6 (50.0) 12 (70.6) 61 (53.5)
7 (58.3) 12 (70.6) 58 (50.9)
2 (16.7) 3 (17.7) 16 (14.0)
3 (25.0) 14 (82.4) 55 (48.3)§
2 (16.7) 4 (23.5) 21 (18.4)
4 (33.3) 13 (76.5) 53 (47.6)§
4 (33.3) 3 (17.7) 16 (14.0)
2 (16.7) 1 (5.9) 5 (4.4)
31.0  10.7 29.2  4.7 30.0  6.3
1.91  0.24 2.02  0.23 1.95  0.24
60.3  10.9 54.1  16.8 59.1  14.5
3 (25.0) 6 (35.3) 34 (29.8)
1 (8.3) 4 (23.5) 12 (10.5)
1 (8.3) 2 (11.8) 10 (8.8)
1 (8.3) 3 (17.7) 6 (5.3)
6 (50.0) 2 (11.8) 52 (45.6)§
†available for 211 of 214 patients; ‡available for 18 of 214
83) MLA >7.5 mm2 (n  131)
B
eferral)
C
(Revascularization)
D
(Deferral)
12 17 114
.7  1.2 2.2  1.0 1.1  0.9†
7 (58.3) 9 (52.9) 73 (64.0)
1 (8.3) 2 (11.8) 18 (15.8)
4 (33.3) 6 (35.3) 23 (20.2)
.2  0.4 2.7  0.6 2.6  0.6†
.5  0.6 4.1  0.7 4.0  0.8†
.0  7.0 33.9  9.3 34.0  12.1
.2  3.2 3.4  2.0 3.6  1.6m2 (n
)
aphy;(n 
(D
1
2
3
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4ss groups A, B, C, D.
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Intravascular Ultrasound and Left Main Disease January 18, 2005:204–11range 0 to 8.2 years) (Table 5, Fig. 2). There was no
ifference in three-year and long-term freedom from
ACE between the patients who were treated according to
he IVUS-guided strategy (groups A and D). Patients in
roup C also had an outcome similar to the patients in
roups A and D, while those in group B had an extremely
igh rate of events. The best cut-off for performing or
eferring revascularization based on the outcome of the
atients deferred for revascularization (groups B and D) by
eceiver operating characteristic was 9.6 mm2 (p  0.062).
nivariate predictors of adverse events among the patients
ho underwent the IVUS-guided strategy (groups A and
) were age, smoking status, number of diseased vessels
excluding the LMCA), left ventricular ejection fraction,
alcium score, and the presence of calcified plaques (Table
). When performing multivariate analysis, age, smoking
tatus, and the number of diseased non-LMCA vessels
emained the only significant predictors of adverse events
Table 7).
able 4. IVUS Characteristics
MLA <7.5 mm2
A
(Revascularization) (D
71
LA (mm2) 5.8  1.1 6
Range (mm2) (3.4–7.4) (4
EM CSA (mm2) 18.9  4.9 19
M CSA (mm2) 13.1  4.7 13
laque burden (%) 67.7  9.0 67
LD (mm) 2.3  0.3 2
aximum lumen diameter (mm) 3.1  0.5 3
laque composition
Soft 11 (15.5) 3
Fibrous 12 (16.9) 3
Mixed 8 (11.3)
Calcified 40 (56.3) 6
Calcium score (mean) 1.3  1.3 1
p  0.05 across groups A, B, C, D.
CSA  cross-sectional area; EEM  external elastic membrane; IVUS  intrav
Table 5. Long-Term Follow-Up
ML
A
(Revascular
n 71
n with follow-up 61 (85
Follow-up period (yrs) 3.2
Range (yrs) (0–7.
Target vessel revascularization 1
Myocardial infarction 7
All-cause death 9
Three-year freedom from MACE (%) 79.2
*p  0.05 across groups A, B, C, D; †p  0.48 across gro
C, D.
MACE  major adverse cardiac events; MLA  minimum lumISCUSSION
he current study demonstrates that IVUS is a safe and
seful tool for therapy guidance in patients with angio-
raphically indeterminate LMCA disease. Moreover, defer-
al of revascularization for patients with an MLA 7.5
m2 appears to be safe.
imitation of angiography and the role of IVUS in
ssessment of LMCA disease. Although it is the method
f choice for coronary disease assessment, angiography
resents several limitations in the evaluation of LMCA
isease (4–8). Apart from interobserver and intraobserver
ifferences in interpretation, the variable anatomy of the
MCA can make assessment difficult because of vessel
verlap, ostial angulation and deformity, foreshortening,
nd streaming of contrast medium from the catheter tip. In
ddition, the two-dimensional silhouette method of angiog-
aphy depicting contrast-filled lumen cannot detect diffuse,
oncentric plaque because of the lack of an undiseased
eference segment for comparison.
MLA >7.5 mm2
Controlal)
C
(Revascularization)
D
(Deferral)
17 114 122
.0 11.2  3.1 11.7  3.6* 16.3 4.3
1) (7.6–19.3) (7.5–25.6) (8.3–28.5)
.3 24.4  5.6 21.4  6.6* 21.5 6.0
.7 13.2  5.5 9.7  5.7* 5.3 3.0
.7 53.4  13.1 42.7  16.2* 23.6  8.3
.2 3.2  0.5 3.3  0.7* 4.2 0.6
.4 4.3  0.7 4.3  0.7* 4.8  0.7
) 3 (17.7) 53 (46.5)* —
) 4 (23.5) 22 (19.3) —
2 (11.8) 7 (6.1) —
) 8 (47.1) 32 (28.1)* —
.6 0.8  1.0 0.6  1.1*
ultrasound; PM  plaque  media; other abbreviations as in Tables 1 and 3.
.5 mm2 MLA >7.5 mm2
n)
B
(Deferral)
C
(Revascularization)
D
(Deferral)
12 17 114
11 (91.7) 16 (94.1) 97 (85.1)
3.0 2.2 3.8 1.7 3.6  2.1*
(0.1–7.1) (1.1–7.3) (0.1–8.4)
4 2 8
1 0 2
2 1 11
49.9 93.8 88.4*†
, C/p  0.28 across groups A, D/p  0.86 across groupsB
eferr
12
.1 1
.3–7.
.6 5
.5 4
.4 7
.4 0
.1 0
(25.0
(25.0
0
(50.0
.3 1A <7
izatio
.9)
2.2
7)
ups Aen area.
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209JACC Vol. 45, No. 2, 2005 Fassa et al.
January 18, 2005:204–11 Intravascular Ultrasound and Left Main DiseaseBy providing a cross-sectional, real-time, tomographic
erspective with direct visualization of the vessel wall, IVUS
an overcome the limitations of angiography. This tech-
ique, which allows accurate assessment of lumen size,
laque area, and intimal composition, has demonstrated
xcellent results for the analysis of coronary artery disease
9–12). Several studies have demonstrated that it is more
ensitive than angiography in detecting early atherosclerosis,
nd shown that it may be helpful for evaluation and
reatment guidance of LMCA lesions that are angiographi-
ally indeterminate (13–19).
ationale for using MLA as the criterion for decision-
aking. There is presently no strict IVUS criterion defin-
ng significant lesions of the LMCA that require revascu-
arization. One approach would be to use the degree of area
tenosis, by analogy to the degree of diameter stenosis used
n angiography, which is obtained by dividing the lumen
rea at the lesion site by the lumen area at a normal
eference site. A 50% diameter stenosis, which is the
ngiographic criterion for defining significant lesions, would
e equivalent to a 75% area stenosis. However, the LMCA,
eing generally a short vessel, may be diffusely diseased,
igure 2. Kaplan-Meier freedom from major adverse cardiac events
MACE). Thin solid line  patients with an minimum lumen artery
MLA) 7.5 mm2 who underwent revascularization (group A); thick
ashed line  patients with an MLA 7.5 mm2 who were deferred for
evascularization (group B); thick solid line  patients with an MLA
7.5 mm2 who underwent revascularization (group C); thin dashed line
patients with an MLA 7.5 mm2 who were deferred for revasculariza-
ion (group D); p  0.05 groups A, B, C, D; p  0.28 across groups A,
; p  0.48 across groups A, C; p  0.86 across groups C, D.
able 6. Univariate Predictors of MACE
Risk Ratio
95% Confidence
Interval
p
Value
ge 1.05 1.01–1.08 0.009
moking* 2.13 1.03–4.42 0.043
jection fraction (%) 0.98 0.95–1.00 0.031
essels diseased† 1.48 1.07–2.03 0.016
alcified plaque 2.52 1.29–4.90 0.007
alcium score 1.33 1.02–1.72 0.035
Active smoking at time of or up to one year before angiography; †number of vesselsr
iseased excluding the left main coronary artery.
MACE  major adverse cardiac events.herefore leaving little opportunity for a normal reference
egment (4,8). Complicating this assessment, LMCA ath-
rosclerosis can be accompanied by arterial remodeling,
hich can be either inward (or “negative”) or outward (or
positive”), and may affect the whole LMCA, even in the
arly stages of atherosclerosis (26,27).
Hence, absolute measurements such as MLA or MLD
as opposed to relative measurements such as lumen area
tenosis and plaque burden) may be more representative of
ow impairment, and, therefore, of long-term outcome.
ndeed, in a study of patients with angiographically ambig-
ous LMCA disease in whom revascularization was de-
erred based on IVUS assessment, Abizaid et al. (15) found
LD to be a predictor of cardiac events at one year.
icciardi et al. (28) showed that in patients with angio-
raphically normal or mild LMCA disease assessed by
VUS, MLA was an independent predictor of clinical
vents. Finally, in another study of patients where PCI was
eferred based on IVUS in non-LMCA coronary arteries,
bizaid et al. (29) also showed event rate to be correlated
ith MLA.
In the present study, we conducted IVUS examinations
n patients who had an angiographically normal or mini-
ally diseased LMCA. The distribution of these patients
hows that there were more patients with a larger MLA
ho were included, with the curve slightly skewed to the
ight. This may be explained by the fact that patients with
smaller MLA were probably less likely to be considered
aving a normal LMCA by visual assessment of the
ngiogram than patients with a larger MLA, leading to a
educed inclusion of the former. Based on this series of
atients, the lower range of normal MLA was defined as 7.5
m2. This result concurs with the finding of Legutko et al.
30), who determined the cut-off for MLA of the LMCA
y correlation with fractional flow reserve to be 8.0 mm2,
ut is somewhat higher than the one from a similar study
hat found a cut-off value of 5.9 mm2 (31). In a recent study,
usso et al. (18) also proposed a 60% area stenosis or an
LA of 5.0 mm2 when no distal reference vessel could be
dentified as a criterion for performing revascularization.
enefit of the IVUS-guided strategy. We prospectively
pplied an IVUS-guided strategy to perform or defer
evascularization of angiographically indeterminate lesions
f the LMCA, based on MLA. This approach was followed
n a majority (86.4%) of the cases. The main reasons for not
ollowing this strategy were the results from fractional flow
eserve assessments of the LMCA lesion, as well as the
eneral condition, comorbidities, and desire of the patients.
he higher extent of coronary disease also influenced the
evascularization of patients with an LMCA lesion consid-
red nonsignificant (group C), and probably influenced the
perators’ decision for revascularization in the patients with
n MLA 7.5 mm2 (group A) as well. In addition, the
igher rate of typical symptoms among these two groups of
atients probably also influenced the decision for
evascularization.
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ith the results usually seen in studies of patients undergo-
ng angiography. This is probably due to the fact that
atients with diabetes are at higher risk of having concom-
tant multivessel disease with an angiographically indeter-
inate LMCA lesion and would, therefore, have a clear
ndication for CABG, thus making them less likely of
ndergoing an additional IVUS examination to determine
he severity of an LMCA lesion.
On angiographic examination, the degree of stenosis,
hich is the main criterion for performing revascularization,
as not significantly different between the four groups,
hile there were significant differences in IVUS quantitative
haracteristics among the different groups. These results
onfirm the findings from earlier studies that demonstrate
he limitations of angiography for the assessment of LMCA
isease, and the usefulness of IVUS for accurately evaluating
esion severity. Moreover, the fact that the patients with an
LA 7.5 mm2 had a smaller EEM CSA as well as a
igher calcium score than the patients with an MLA 7.5
m2 suggests that inward remodeling and coronary calcifi-
ation may interfere with the accuracy of assessment of
MCA disease by coronary angiography.
There was no significant difference in the rate of adverse
vents on long-term follow-up between the patients who
ere treated according to the IVUS-guided strategy (groups
and D). Furthermore, revascularization of the patients
ith an MLA 7.5 mm2 (group C) did not result in any
ignificant benefit compared with those with an MLA7.5
m2 who were deferred for revascularization. This, there-
ore, suggests that deferral of revascularization for patients
ith an MLA 7.5 mm2 is safe. In addition, deferral of
evascularization for patients with an MLA 7.5 mm2 is
ssociated with a very poor outcome and should, therefore,
e avoided.
The MLA cut-off for performing revascularization based
n the outcome of the patients deferred for revascularization
groups B and D) was 9.6 mm2, which is higher than the
alue of 7.5 mm2 that was prospectively used in this study.
his gap suggests that other factors in addition to MLA
hould probably be taken into account for decision-making
n the appropriate treatment for patients with an MLA in
he “gray zone” between 7.5 and 9.6 mm2, such as the
ultivariate predictors of events, which were the extent of
oronary disease, the smoking status, and the age.
The predictors of events by mutlivariate analysis differed
able 7. Multivariate Predictors of MACE
Hazard Ratio
95% Confidence
Interval p Value
ge 1.05 1.02–1.09 0.004
moking* 2.42 1.13–5.14 0.022
essels diseased† 1.39 1.01–1.90 0.044
Active smoking at time of or up to one year before angiography; †number of vessels
iseased excluding the left main coronary artery.
MACE  major adverse cardiac events.rom the ones in the study by Abizaid et al. (15), who foundiabetes, untreated vessel, and MLD by IVUS to be
ssociated with outcome. This can probably be explained by
he differences in baseline characteristics (lower rates of
iabetes, prior CABG, and PCI in the present study) and
esign between the two studies.
Finally, it is important to mention the usefulness of a
ractional flow-reserve-guided strategy for patients with
ngiographically intermediate LMCA lesions, as reported
y Bech et al. (32). Fractional flow reserve is certainly a
eliable alternative for the assessment of indeterminate
MCA lesions in instances where IVUS is technically
roblematic (cases where the IVUS catheter cannot be
aintained coaxial to the LMCA during pull-back, and
here quantitative assessments of IVUS findings is difficult
ue to severe calcification or obscure IVUS imagery).
urthermore, a combination of physiologic assessment of
MCA disease by fractional flow reserve together with
VUS could provide more complete guidance for revascu-
arization than any of the methods alone, as reported by
ecent studies (30,31,33).
tudy limitations. The purpose of this study was to assess
given treatment strategy in clinical practice. It was
onducted in a nonrandomized fashion and, therefore,
uffers from the limitations associated with its design.
evertheless, the IVUS-guided strategy was implemented
n a prospective way, and was carried out in a majority of the
ases.
In the present study, acute revascularization was per-
ormed mainly through CABG (there were only two cases
f PCI of a protected LMCA, and no PCI of an unpro-
ected LMCA). At the present time, PCI of LMCA
erformed by experienced operators in several centers is
ncreasing (34,35). Therefore our study may not entirely
eflect the current reality of LMCA revascularization. Nev-
rtheless, revascularization was carried out in all cases
espectful of the current guidelines.
onclusions. Our study shows that IVUS is a safe method
o accurately assess the degree of disease in the LMCA that
ppears indeterminate by angiography. It also suggests that
n IVUS-guided treatment strategy based on deferral of
evascularization in patients with MLA 7.5 mm2 is safe.
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